Patents Assigned to Ontherix, Inc.
  • Adaptive biochemical signatures
    Patent number: 8536135
    Abstract: The present invention is related to methods of generating adaptive biochemical signatures in live cells and the use of said signatures to identify diagnostic and therapeutic modalities for human disease. The methods described herein comprise contacting a provocative agent to live cells and measuring and analyzing adaptive readouts. The methods of the invention may be used for therapeutic or diagnostic purposes.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: September 17, 2013
    Assignee: Ontherix, Inc.
    Inventor: Desmond Mascarenhas
  • ADAPTIVE BIOCHEMICAL SIGNATURES
    Publication number: 20110202281
    Abstract: The present invention is related to methods of generating adaptive biochemical signatures in live cells and the use of said signatures to identify diagnostic and therapeutic modalities for human disease. The methods described herein comprise contacting a provocative agent to live cells and measuring and analyzing adaptive readouts. The methods of the invention may be used for therapeutic or diagnostic purposes.
    Type: Application
    Filed: March 19, 2009
    Publication date: August 18, 2011
    Applicant: ONTHERIX, INC.
    Inventor: Desmond Mascarenhas
  • Metal-binding therapeutic peptides
    Patent number: 7662624
    Abstract: The present invention is related methods of delivering MBD peptide-linked agents into live cells. The methods described herein comprise contacting MBD peptide-linked agents to live cells under a condition of cellular stress. The methods of the invention may be used for therapeutic or diagnostic purposes.
    Type: Grant
    Filed: March 19, 2008
    Date of Patent: February 16, 2010
    Assignee: Ontherix, Inc.
    Inventor: Desmond Mascarenhas
  • Metal-binding therapeutic peptides
    Patent number: 7618816
    Abstract: The present invention is related methods of delivering MBD peptide-linked agents into live cells. The methods described herein comprise contacting MBD peptide-linked agents to live cells under a condition of cellular stress. The methods of the invention may be used for therapeutic or diagnostic purposes.
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: November 17, 2009
    Assignee: Ontherix, Inc.
    Inventor: Desmond Mascarenhas
  • Metal-binding therapeutic peptides
    Patent number: 7611893
    Abstract: The present invention is related methods of delivering MBD peptide-linked agents into live cells. The methods described herein comprise contacting MBD peptide-linked agents to live cells under a condition of cellular stress. The methods of the invention may be used for therapeutic or diagnostic purposes.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: November 3, 2009
    Assignee: Ontherix, Inc.
    Inventor: Desmond Mascarenhas